140 related articles for article (PubMed ID: 19596656)
1. Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.
Koppen A; Houtman R; Pijnenburg D; Jeninga EH; Ruijtenbeek R; Kalkhoven E
Mol Cell Proteomics; 2009 Oct; 8(10):2212-26. PubMed ID: 19596656
[TBL] [Abstract][Full Text] [Related]
2. Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ.
Kilu W; Merk D; Steinhilber D; Proschak E; Heering J
J Biol Chem; 2021 Jul; 297(1):100814. PubMed ID: 34081964
[TBL] [Abstract][Full Text] [Related]
3. PPARγ S273 Phosphorylation Modifies the Dynamics of Coregulator Proteins Recruitment.
Dias MMG; Batista FAH; Tittanegro TH; de Oliveira AG; Le Maire A; Torres FR; Filho HVR; Silveira LR; Figueira ACM
Front Endocrinol (Lausanne); 2020; 11():561256. PubMed ID: 33329381
[TBL] [Abstract][Full Text] [Related]
4. Enhanced detection of ligand-PPARγ binding based on surface plasmon resonance through complexation with SRC1- or NCOR2-related polypeptide.
Wang Y; Luo M; Che L; Wu Q; Li J; Ma Y; Wang J; Liu C
Int J Biol Macromol; 2024 May; 268(Pt 1):131865. PubMed ID: 38670200
[TBL] [Abstract][Full Text] [Related]
5. Engineering and optimization of an allosteric biosensor protein for peroxisome proliferator-activated receptor γ ligands.
Li J; Gierach I; Gillies AR; Warden CD; Wood DW
Biosens Bioelectron; 2011 Nov; 29(1):132-9. PubMed ID: 21893405
[TBL] [Abstract][Full Text] [Related]
6. Ligand efficacy shifts a nuclear receptor conformational ensemble between transcriptionally active and repressive states.
MacTavish B; Zhu D; Shang J; Shao Q; Yang ZJ; Kamenecka TM; Kojetin DJ
bioRxiv; 2024 Apr; ():. PubMed ID: 38712087
[TBL] [Abstract][Full Text] [Related]
7. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.
Lee JW; Choi HS; Gyuris J; Brent R; Moore DD
Mol Endocrinol; 1995 Feb; 9(2):243-54. PubMed ID: 7776974
[TBL] [Abstract][Full Text] [Related]
8. NUFIP1 is a ribosome receptor for starvation-induced ribophagy.
Wyant GA; Abu-Remaileh M; Frenkel EM; Laqtom NN; Dharamdasani V; Lewis CA; Chan SH; Heinze I; Ori A; Sabatini DM
Science; 2018 May; 360(6390):751-758. PubMed ID: 29700228
[TBL] [Abstract][Full Text] [Related]
9. Mapping the Protein Kinome: Current Strategy and Future Direction.
Hou Z; Liu H
Cells; 2023 Mar; 12(6):. PubMed ID: 36980266
[TBL] [Abstract][Full Text] [Related]
10. PPARγ lipodystrophy mutants reveal intermolecular interactions required for enhancer activation.
Madsen MS; Broekema MF; Madsen MR; Koppen A; Borgman A; Gräwe C; Thomsen EGK; Westland D; Kranendonk MEG; Koerkamp MG; Hamers N; Bonvin AMJJ; Pittol JMR; Natarajan KN; Kersten S; Holstege FCP; Monajemi H; van Mil SWC; Vermeulen M; Kragelund BB; Cassiman D; Mandrup S; Kalkhoven E
Nat Commun; 2022 Nov; 13(1):7090. PubMed ID: 36402763
[TBL] [Abstract][Full Text] [Related]
11. Physiological Convergence and Antagonism Between GR and PPARγ in Inflammation and Metabolism.
Dacic M; Shibu G; Rogatsky I
Adv Exp Med Biol; 2022; 1390():123-141. PubMed ID: 36107316
[TBL] [Abstract][Full Text] [Related]
12. Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer.
Gallez A; Blacher S; Maquoi E; Konradowski E; Joiret M; Primac I; Gérard C; Taziaux M; Houtman R; Geris L; Lenfant F; Marangoni E; Sounni NE; Foidart JM; Noël A; Péqueux C
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065180
[TBL] [Abstract][Full Text] [Related]
13. A mutant form of ERα associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment.
Li Y; Coons LA; Houtman R; Carlson KE; Martin TA; Mayne CG; Melchers D; Jefferson TB; Ramsey JT; Katzenellenbogen JA; Korach KS
Sci Signal; 2020 Sep; 13(650):. PubMed ID: 32963012
[TBL] [Abstract][Full Text] [Related]
14. The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity.
Koorneef LL; Kroon J; Viho EMG; Wahl LF; Heckmans KML; van Dorst MMAR; Hoekstra M; Houtman R; Hunt H; Meijer OC
J Endocrinol; 2020 Jul; 246(1):79-92. PubMed ID: 32369774
[TBL] [Abstract][Full Text] [Related]
15. A Model of Glucocorticoid Receptor Interaction With Coregulators Predicts Transcriptional Regulation of Target Genes.
Monczor F; Chatzopoulou A; Zappia CD; Houtman R; Meijer OC; Fitzsimons CP
Front Pharmacol; 2019; 10():214. PubMed ID: 30930776
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid Action in the Brain: The Potential of Selective Receptor Modulation.
Viho EMG; Buurstede JC; Mahfouz A; Koorneef LL; van Weert LTCM; Houtman R; Hunt HJ; Kroon J; Meijer OC
Neuroendocrinology; 2019; 109(3):266-276. PubMed ID: 30884490
[TBL] [Abstract][Full Text] [Related]
17. Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models.
Sugawara T; Baumgart SJ; Nevedomskaya E; Reichert K; Steuber H; Lejeune P; Mumberg D; Haendler B
Int J Cancer; 2019 Sep; 145(5):1382-1394. PubMed ID: 30828788
[TBL] [Abstract][Full Text] [Related]
18. Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.
Broekema MF; Massink MPG; Donato C; de Ligt J; Schaarschmidt J; Borgman A; Schooneman MG; Melchers D; Gerding MN; Houtman R; Bonvin AMJJ; Majithia AR; Monajemi H; van Haaften GW; Soeters MR; Kalkhoven E
Mol Metab; 2019 Feb; 20():115-127. PubMed ID: 30595551
[TBL] [Abstract][Full Text] [Related]
19. The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells.
Fanning SW; Jeselsohn R; Dharmarajan V; Mayne CG; Karimi M; Buchwalter G; Houtman R; Toy W; Fowler CE; Han R; Lainé M; Carlson KE; Martin TA; Nowak J; Nwachukwu JC; Hosfield DJ; Chandarlapaty S; Tajkhorshid E; Nettles KW; Griffin PR; Shen Y; Katzenellenbogen JA; Brown M; Greene GL
Elife; 2018 Nov; 7():. PubMed ID: 30489256
[TBL] [Abstract][Full Text] [Related]
20. Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations.
Jeselsohn R; Bergholz JS; Pun M; Cornwell M; Liu W; Nardone A; Xiao T; Li W; Qiu X; Buchwalter G; Feiglin A; Abell-Hart K; Fei T; Rao P; Long H; Kwiatkowski N; Zhang T; Gray N; Melchers D; Houtman R; Liu XS; Cohen O; Wagle N; Winer EP; Zhao J; Brown M
Cancer Cell; 2018 Feb; 33(2):173-186.e5. PubMed ID: 29438694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
